Drug Profile
Carbidopa/entacapone/levodopa - LobSor Pharmaceuticals
Alternative Names: Carbidopa monohydrate/entacapone/levodopa - LobSor Pharmaceuticals; Entacapone/levodopa/carbidopa - LobSor Pharmaceuticals; LECIGel; LECIGon; Lecigon; Levodopa/carbidopa/entacapone - LobSor Pharmaceuticals; TRIGEL - LobSor PharmaceuticalsLatest Information Update: 06 Jan 2022
Price :
$50
*
At a glance
- Originator LobSor Pharmaceuticals
- Class Amides; Antiparkinsonians; Catecholamines; Catechols; Hydrazines; Nitriles; Nitrophenols; Small molecules
- Mechanism of Action Catechol O-methyltransferase inhibitors; Decarboxylase inhibitors; Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Parkinson's disease